Table 3.
Association of eGFR with Atrial Fibrillation
| Measure and Outcome | ||
|---|---|---|
|
eGFR and Prevalent atrial fibrillation |
||
| Range of Values — ml/min/1.73m2 |
≥60 | <60 |
| No. | 4027 | 636 |
| No. with atrial Fibrillation |
268 | 74 |
| Odds Ratio (95% CI) | ||
| Unadjusted | 1.00 | 1.92 (1.45-2.56) |
| Adjusted* | 1.00 | 1.22 (0.89-1.66) |
|
eGFR and Incident atrial fibrillation |
||
| Range of Values — ml/min/1.73m2 |
≥60 | <60 |
| No. at risk | 3759 | 562 |
| No. with atrial Fibrillation |
494 | 85 |
| Hazard Ratio (95% CI) | ||
| Unadjusted | 1.00 | 1.29(1.02-1.64) |
| Adjusted* | 1.00 | 0.92 (0.72-1.19) |
*
Adjusted for age, gender, race, diabetes, CRP, LDL, HDL, prevalent CHD, prevalent CHF, left ventricular hypertrophy, SBP, DBP, use of angiotensin converting enzyme inhibitor, beta blocker, calcium channel blocker and diuretic.